StonvexLoading…
StonvexCore line items from NI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.32B | $6.52B | $4.64B | $3.40B |
Operating Income | $819.20M | $1.84B | $1.32B | $1.02B |
Net Income | $507.10M | $929.50M | $671.70M | $577.00M |
EPS (Diluted) | $1.06 | $1.95 | $1.42 | $1.22 |
Total Assets | $36.60B | $35.86B | $34.40B | $34.03B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $71.90M | $110.10M | $95.00M | $335.40M |
Free Cash Flow OCF − CapEx | $-362.90M | $-420.00M | $-286.30M | $-113.70M |
Shares Outstanding | 479.36M | 478.43M | 477.14M | 470.78M |